AzTrials
AzTrials

Sedentary LifestyleNCT03473145

Sedentary Behavior Interrupted Randomized Controlled Trial (P2)

A study testing Health Coaching, activPAL inclinometer and Tools to Prompt Standing or Prompt Sit-to-Stand Transitions. in people with Sedentary Lifestyle, run by University of California, San Diego at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Epidemiological findings indicate that older adults do not meet physical activity (PA) guidelines \& spend up to 11 hrs/day sitting. Given the high prevalence of sedentary behavior (SB), the higher chronic disease risk in this population, \& the age-associated challenges of meeting traditional PA guidelines, involving… Read more about this study

Who is it for?
Ages 55 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Sedentary Lifestyle
What is being tested?
Health Coaching, activPAL inclinometer and Tools to Prompt Standing or Prompt Sit-to-Stand Transitions.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
407 participants
Where
1 siteUnited States
Study dates
30 May 2018to 31 Dec 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Female;
  • 55 years of age and above;
  • any ethnicity or race;
  • screened to sit for 7 or more hours per day, perform less than 70 sit-to-stand transitions per day
  • ambulatory;
  • medically stable without any health conditions that would inhibit standing or PA;
Show all 12Show fewer
  • able to give informed consent \& comply with study protocols;
  • able to read and write fluently in English;
  • able to travel to study visits; and
  • no menstruation for at least one year;
  • BMI 25-45
  • able to walk, stand and transition without high risk of falling.

Who cannot join

  • Male;
  • younger than 55 years of age;
  • sit for less than 7 hours per day, perform 71 or more sit-to-stand transitions per day
  • mental state that would preclude complete understanding of the protocol or compliance;
  • physical limitations to completing any of the study conditions;
  • menstruation less than one year prior;
Show all 10Show fewer
  • unable to complete the Short Physical Performance Battery,
  • Active cancer
  • body Mass Index <25 or >45kg/m2,
  • use of insulin

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UC San Diego

    La Jolla, California, 92093

Other trials in United States

About this study

Official title: Sedentary Behavior Interrupted: A Randomized Trial of 3-month Effects on Biomarkers of Healthy Aging and Physical Functioning in the Real World (Project 2)

Epidemiological findings indicate that older adults do not meet physical activity (PA) guidelines \& spend up to 11 hrs/day sitting. Given the high prevalence of sedentary behavior (SB), the higher chronic disease risk in this population, \& the age-associated challenges of meeting traditional PA guidelines, involving longer bouts of moderate PA, the investigators hypothesize that older adult health will benefit from new strategies to interrupt sitting. This protocol "Sedentary Behavior Interrupted: A randomized trial of 3-month effects on biomarkers of healthy aging and physical functioning in the real world (Project 2)" is part of a National Institutes of Aging Program Grant called "Sedentary Time \& Aging Mortality and Physical Function (STAR). The overall purpose of the STAR program to is to better understand how to interrupt sitting time and the consequences for healthy aging in postmenopausal women. This protocol (also referred to Project 2 of the STAR program) is a 3-arm randomized control trial designed to assess ways of interrupting sitting in 405 overweight, postmenopausal women.

Read the detailed description

Primary Aims:

In our primary biomarker outcomes of glucose regulation (fasting insulin \& glucose, HbA1c, HOMA-IR) \& blood pressure (BP):

  1. Investigate the 12 week effects of increased standing and additional brief sit-to-stand compared to attention controls.
  2. Investigate the dose-response effects of behavioral change on the biomarkers \& BP.

Secondary aims

  1. Assess the effect of changes in standing and sit-to-stand transitions at 12 weeks on physical, emotional \& cognitive functioning.
  2. Assess the effect of changes in standing and sit-to-stand transitions at 12 weeks on in vivo skeletal muscle mitochondrial function.

Exploratory aims

  1. Explore the possible modifying effect of age on the relationship between intervention conditions \& primary \& secondary outcomes.
  2. Explore the psychosocial \& environmental mediators \& moderators of changes in sitting time, standing time, and transitions.
  3. Explore differences in outcomes between the 2 sitting interruption conditions.
Being tested
Health Coaching, activPAL inclinometer, Tools to Prompt Standing or Prompt Sit-to-Stand Transitions.
Medical subject headings
Sedentary Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Health CoachingBehavioural

    Health Coaching sessions will be aimed at goal setting, implementing strategies, overcoming barriers, \& relapse prevention.

  • activPAL inclinometerDevice

    Participants in the intervention study arms (B \& C) will wear the ActivPAL device for the first 4 weeks of the program and then again in weeks 8 and 9. The device will monitor their sitting and standing time and will allow Health Coaches to provide feedback and will assist the participant in developing an action plan.

  • Tools to Prompt Standing or Prompt Sit-to-Stand Transitions.Other

    Participants in the intervention study arms (B \& C) will receive tools to prompt standing or sit-to-stand transitions such as wearable wrist devices, standing desks or tables (Group B only), mechanical and/or electronic timers, or access to mobile apps or computer programs.

Study groups in NCT03473145
Study groupRoleWhat they receive
Health Living Attention ControlActive comparatorParticipants in the attention control condition will receive a healthy aging educational intervention. This group will receive one in-person health coaching sessions and 6 phone counseling sessions.
Receives: Behavioral: Health Coaching
Reduce SittingExperimentalParticipants in the Reduce Sitting condition will receive an intervention aimed at reducing daily sitting time. This group will receive five in-person health coaching sessions and two phone counseling sessions.
Receives: Behavioral: Health Coaching; Device: activPAL inclinometer; Other: Tools to Prompt Standing or Prompt Sit-to-Stand Transitions.
Sit-to-Stand TransitionExperimentalParticipants in the Sit-to-Stand Transition condition will receive an intervention aimed at increasing the daily number of brief sit-to-stand transitions. This group will receive five in-person health coaching sessions and two phone counseling sessions.
Receives: Behavioral: Health Coaching; Device: activPAL inclinometer; Other: Tools to Prompt Standing or Prompt Sit-to-Stand Transitions.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Insulin Regulation (mU/L)

    Mean Insulin (mU/L) collected via fasting blood draw at Baseline and 3-Months

    Measured: 3 months

Secondary outcomes (1)
  1. Self-Reported Physical Functioning

    Self-reported physical functioning was assessed using the Rand SF 36-Item Health Survey that assesses 8 health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. The range of scores is 0 - 100 with higher scores meaning better physical functioning.

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Mar 2018
  2. Study start30 May 2018
  3. Primary completion31 Dec 2022
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
407 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03473145
Sponsor's protocol ID
1P01AG052352-01A1
Status last verified
Sep 2025
First submitted
14 Mar 2018
Last updated
3 Nov 2025
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Hartman SJ, LaCroix AZ, Sears DD, Natarajan L, Zablocki RW, Chen R, Patterson JS, Dillon L, Sallis JF, Schenk S, Dunstan DW, Owen N, Rosenberg DE. Impacts of Reducing Sitting Time or Increasing Sit-to-Stand Transitions on Blood Pressure and Glucose Regulation in Postmenopausal Women: Three-Arm Randomized Controlled Trial. Circulation. 2025 Aug 26;152(8):492-504. doi: 10.1161/CIRCULATIONAHA.124.073385. Epub 2025 Jul 25.

    PubMed 40709462
  • Zablocki RW, Hartman SJ, Di C, Zou J, Carlson JA, Hibbing PR, Rosenberg DE, Greenwood-Hickman MA, Dillon L, LaCroix AZ, Natarajan L. Using functional principal component analysis (FPCA) to quantify sitting patterns derived from wearable sensors. Int J Behav Nutr Phys Act. 2024 Apr 26;21(1):48. doi: 10.1186/s12966-024-01585-8.

    PubMed 38671485
  • Hartman SJ, Dillon LW, LaCroix AZ, Natarajan L, Sears DD, Owen N, Dunstan DW, Sallis JF, Schenk S, Allison M, Takemoto M, Herweck AM, Nguyen B, Rosenberg DE. Interrupting Sitting Time in Postmenopausal Women: Protocol for the Rise for Health Randomized Controlled Trial. JMIR Res Protoc. 2021 May 13;10(5):e28684. doi: 10.2196/28684.

    PubMed 33983131

Questions about this trial

What is this clinical trial studying?

A study testing Health Coaching, activPAL inclinometer and Tools to Prompt Standing or Prompt Sit-to-Stand Transitions. in people with Sedentary Lifestyle, run by University of California, San Diego at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 3 Nov 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Insulin Regulation (mU/L) (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03473145, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in